Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Bayer Raises Earnings Outlook on Pharma Recovery
raised its full-year earnings guidance, citing a recovery in its pharmaceutical arm after strong demand for key drugs allowed the group to offset market pressures at its agricultural and consumer-health divisions. The German group said Tuesday that…
Pharma's next cash cows could be specialized treatments
Pharmaceutical companies facing a steep patent cliff are concluding the key to future profits may be customized treatments tailored to patients' genes and lifestyles — not blockbusters aimed at large patient populations. Why it matters: The…
Should You Invest $1,000 in BridgeBio Pharma Right Now?
BridgeBio Pharma (BBIO +5.97%) is a biotech on the verge of a breakout. The company focuses on rare genetic diseases. It has only two approved therapies right now: Attruby and Nulibry. Attruby is the company's main earner right now. The drug treats…
Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says
Four major Western pharmaceutical companies paid tens of millions of dollars in unusually high bonuses to Russian middlemen to supply cancer drugs to state hospitals, according to whistleblower documents submitted to U.S. financial regulators. The…
Switzerland celebrates fifth three-star Michelin restaurant
‘Maximum discretion' is a thing of the past: Swiss politicians step onto the world stage Read more: ‘Maximum discretion' is a thing of the past: Swiss politicians step onto the world stage Alain Werner: a life spent fighting impunity…
Switzerland faces pressure from US drug pricing policy
Swiss drug prices are already among the highest in the world, but prices in the US are significantly steeper. The US government wants to change that and is pressuring pharmaceutical companies to offer new medicines at lower prices in the American…
SWISS profits rise despite high fuel costs
The airline explained that the high demand for air travel and the encouraging performance of the cargo business had more or less offset the additional fuel costs. Turnover rose by 5.3% to CHF4.38 billion. However, SWISS was barely able to improve…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $14.88, but opened at $14.23. Ascentage Pharma Group International…
Indian Stock Market Rally Continues: Sensex Jumps 615 Points Amidst Global Cues
Indian benchmark indices Sensex and Nifty extended their rally in early trade, driven by a significant correction in crude oil prices and robust foreign fund inflows, signalling continued positive momentum for the market. Benchmark indices Sensex…
Q2 Results 03rd Nov Oct Live: SBI, NSE, Bajaj Finserv, Solar Ind, Fortis, Gujarat Fluoro, Bajaj Holdings, Lloyds Metals & Energy, Lupin, MCX, Emcure Pharma, AIA Engineering, Zydus Wellness to announce Q2 results, ITC, Marico, NALCO, Granules, MobiKwik shares in focus
Q2 Results Today, 03rd November 2026 Live Updates: Among the major and closely watched companies scheduled to announce their Q2 FY27 results on November 3, 2026, are Bajaj Finserv, State Bank of India (SBI), Bajaj Holdings & Investment, Lupin, AIA…
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo
AbbVie (ABBV +1.41%) has already pulled off one of the great commercial pivot stories in pharmaceutical history. When Humira -- once pharma's top-selling drug -- lost patent exclusivity, the Chicago-based company leaned on Skyrizi and Rinvoq, which…
Sensex jumps nearly 596 points, Nifty opens higher
Indian equity markets opened higher for the second consecutive session on Tuesday, extending the ongoing rally as investors remained optimistic about improving second-quarter earnings, foreign institutional investors turning buyers, and easing…
Stock markets extend rally in early trade; Sensex jumps 615 points
Benchmark indices Sensex and Nifty continued their winning run in early trade on Tuesday (November 3, 2026) amid a sharp correction in crude oil prices and foreign fund inflows. The 30-share BSE Sensex jumped 614.66 points to 76,301.63 in early…
AimedBio Reports First Patient Dosed in Boehringer Ingelheim Phase I Trial
AimedBio says the first patient has been dosed in a Phase I study of a cancer drug it licensed to Boehringer Ingelheim, marking a clinical milestone as the German drugmaker expands its research ties in South Korea. AimedBio announced the milestone…
India has never allowed import of GM products, will not do so in future: Goyal
'We are very sensitive to opening up to certain agricultural produce, certain goods that we are very strong on like marine products. We are very sensitive to opening our dairy. In fact, till date, we have never opened up dairy for anybody. 'We are…
Receive a Daily briefing on Pharma Industry News
Get Started